- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06068504
Shear Stress in the Arteries of the Lower Limbs During Exercise in Patients With Peripheral Arterial Disease
February 11, 2026 updated by: Raphael Mendes Ritti Dias, University of Nove de Julho
Shear Stress in the Arteries of the Lower Limbs During Arm Cranking Exercise in Patients With Peripheral Arterial Disease
The aim of the study will be to evaluate shear stress and blood flow parameters in lower limb arteries during arm cycle ergometer exercise in participants with peripheral artery disease.
Twenty patients participants with peripheral artery disease and claudication symptoms will be recruited.
Participants will perform 3 experimental sessions in random order.
Iarm-cranking (15 sets of two minutes exercise), warm water foot immersion, and control.
During the interventions, blood pressure and heart rate will be assessed every 6 minutes.
Measurements of arterial diameter, blood flow, anterograde and retrograde shear stress of the femoral artery will be evaluated using a two-dimensional ultrasound device with spectral Doppler.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 01504-001
- University Nove de Julho
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- clinical diagnosis of peripheral artery disease or ankle-brachial index less than 0.90 in one or both limbs
- do not present peripheral neuropathy;
- be able to exercise after medical approval
- aged 50 or over.
Exclusion Criteria:
- Medication change during the study
- Health problems that contraindicates the practice of physical exercise.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm-cranking exercise
Patients will be perform arm-cranking exercise.
The exercise will be performed in 15 sets of 2 min of exercise at a moderate intensity (13-15 in Borg scale)
|
Arm-cranking exercise
Other Names:
|
|
Active Comparator: Heating
Patients will perform 15 sets of 2 min of immersion of their foot in a warm water (42 degrees)
|
Immersion of the foot in warm water
|
|
No Intervention: Control
Patients will remain seated for 60 min
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Femoral artery diameter [mm]
Time Frame: Before the intervention and at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 minutes into the intervention
|
Measurements will be obtained through duplex ultrasound in accordance with global recommendations.
|
Before the intervention and at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 minutes into the intervention
|
|
Femoral artery shear rate [sec.-1]
Time Frame: Before the intervention and at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 minutes into the intervention
|
Measurements will be obtained through duplex ultrasound in accordance with global recommendations.
|
Before the intervention and at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 minutes into the intervention
|
|
Femoral artery Blood flow [mL/min]
Time Frame: Before the intervention and at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 minutes into the intervention
|
Measurements will be obtained through duplex ultrasound in accordance with global recommendations.
|
Before the intervention and at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30 minutes into the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brachial systolic and diastolic blood pressure [mmHg]
Time Frame: Before the intervention and at 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, and 29 minutes into the intervention
|
Systolic and diastolic blood pressures will be assessment in the arms with an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan)
|
Before the intervention and at 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, and 29 minutes into the intervention
|
|
Heart rate [bpm]
Time Frame: Before and up to 30 minutes into the intervention
|
Heart rate assessment with a heart rate monitor (Polar H10, Polar®, Finland)
|
Before and up to 30 minutes into the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Raphael Dias, University of Nove de Julho
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Actual)
November 30, 2025
Study Completion (Actual)
November 30, 2025
Study Registration Dates
First Submitted
September 22, 2023
First Submitted That Met QC Criteria
September 28, 2023
First Posted (Actual)
October 5, 2023
Study Record Updates
Last Update Posted (Actual)
February 12, 2026
Last Update Submitted That Met QC Criteria
February 11, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Vascular Diseases
- Cardiovascular Diseases
- Atherosclerosis
- Arteriosclerosis
- Arterial Occlusive Diseases
- Peripheral Vascular Diseases
- Behavior
- Peripheral Arterial Disease
- Motor Activity
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Investigative Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Environment and Public Health
- Environment
- Environment, Controlled
- Diagnostic Techniques, Respiratory System
- Diagnostic Techniques, Cardiovascular
- Heart Function Tests
- Respiratory Function Tests
- Ergometry
- Exercise
- Exercise Test
- Heating
Other Study ID Numbers
- Heating_PAD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
One year after the study completion
IPD Sharing Access Criteria
Upon request
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Marissa JarosinskiTerminatedPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Wroclaw Medical UniversityPoznan University of Medical Sciences; Military Institute of Medicine National...RecruitingPeripheral Arterial Disease(PAD)Poland
-
BayerCompleted
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
Clinical Trials on Arm-cranking exercise
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation TrustCompletedQuality of Life | Systemic Sclerosis | Raynaud's PhenomenonUnited Kingdom
-
Swiss Paraplegic Centre NottwilCompleted
-
Swiss Paraplegic Research, NottwilCompletedSpinal Cord InjuriesSwitzerland
-
Case Western Reserve UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMultiple SclerosisUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
University of AlcalaRecruitingAxillary Web SyndromeSpain
-
Capital University of Physical Education and Sports...Not yet recruitingEffects of Exercise on Older AdultsChina
-
University of California, San FranciscoNational Cancer Institute (NCI)Completed
-
National Taiwan University HospitalCompletedSystematically Intermittent Arm Exercise for Improving Maturation of Hemodialysis Arteriovenous ShuntTaiwan
-
University of California, IrvineEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed